1 diabetes mellitus has focused attention on the mechalitus despite a normal or low plasma renin activity level have nisms by which the ACE inhibitor works [1] . Studies in suggested intrarenal activation of the renin-angiotensin system in this disease. There is, however, a continuing debate as to humans and in animals have suggested that renal hemothe mediators of the renal hemodynamic response to ACE dynamics contribute to the pathogenesis [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . The mechanism responsible for the acute and often dramicroalbuminuria and on a high-salt diet were given the ACE matic vasodilator response to captopril has not been inhibitor captopril (25 mg orally) on one day and the AT 1 clearly defined. One possibility involves a reduction in receptor blocker candesartan (16 mg orally) on another day.
angiotensin II (Ang II) formation, but there is an alternaRenal plasma flow (RPF) and glomerular filtration rate were tive possibility involving activation of vasodilator pathmeasured before and for four hours after administration.
Results. Both drugs caused a significant increase in RPF ways via bradykinin accumulation, prostaglandin forma- tion, and activation of nitric oxide synthesis [22] .
candesartan 577 Ϯ 26 to 643 Ϯ 37, P ϭ 0.004). There was a
In this study, we have assessed the mechanism responhighly significant correlation between the responses to captosible for the accentuated renal hemodynamic response pril and to candesartan (r ϭ 0.86, P Ͻ 0.001). Seven subjects to captopril in patients with type 1 diabetes mellitus by had an RPF response to captopril that was accentuated (90 Ϯ 13 mL/min/1.73 m 2 ), while five had a response that was normal comparing that response to the response induced by an (Ϫ4 Ϯ 9). There was no significant change in glomerular filtraAng II subtype 1 (AT 1 ) receptor blocker, candesartan.
tion rate on either drug.
Our hypothesis was that the responses would correlate candesartan indicates that reduced angiotensin II formation is the main mechanism of action of the ACE inhibitor.
METHODS

Subjects and protocols
We studied 12 men and women with type 1 diabetes mellitus who ranged in age from 17 to 50 years (mean Ϯ SEM, 32 Ϯ 4.0). The duration of diabetes ranged from metabolic ward at the General Clinical Research Center ated immediately at a rate of 12 and 30 mg/min, respectively, with an IMED pump (Alaris Medical System, (GCRC) at the Brigham and Women's Hospital, where balance was achieved on a controlled diet.
San Diego, CA, USA). This achieved a plasma PAH concentration in the middle of the range in which tubular All subjects were placed on a high-salt isocaloric diet starting two days prior to admission and continuing secretion dominates excretion. At this plasma level of PAH, clearance is independent of plasma concentration throughout the hospitalization, with a daily sodium intake of 200 mmol. Daily dietary potassium (100 mmol) and represents approximately 90% of RPF when corrected for individual body surface area. Likewise, at the and fluid intake (2500 mL) were constant. Twenty-fourhour urine samples were collected daily and analyzed for level of plasma inulin achieved, inulin clearance reflects GFR. RPF and GFR determinations were made at basesodium, potassium, creatinine, and protein. The protocol was approved by the Human Subjects Committee of the line and at 45-minute intervals thereafter until 225 minutes (ϳ4 h) while the subjects were supine. institution, and written-informed consent was obtained from each subject.
Laboratory procedures Renal hemodynamic and hormonal responses to
Blood samples were collected on ice and spun immedicaptopril and candesartan ately, and the plasma was frozen until assay. Urinary and serum sodium and potassium levels were measured Each subject participated in two experimental days. On the morning of each study day, an intravenous catheusing the ion-selective electrode. PAH and inulin were measured using an autoanalyzer technique. Plasma renin ter was placed in each arm of each subject, one for infusion of p-aminohippurate (PAH), inulin, and dexactivity (PRA) and aldosterone were determined by radioimmunoassay [24, 25] . Hemoglobin A1C (HbA1C) trose 5% in water and the other for blood sampling. A third intravenous line was placed for continuous infusion was measured by high-performance liquid chromatograof insulin that was started at 0.015 U/kg/h. Blood glucose phy. The normal range is 4.4 to 6.3%. was measured every 30 minutes (Precision PCX; Abbott Analyses Laboratories, Chicago, IL, USA). The insulin infusion was adjusted to maintain blood glucose below the renal Group means were calculated with the SEM as the threshold but without inducing hypoglycemia, at levels index of dispersion. For renal hemodynamic data, the of 100 to 140 mg/dL. The subjects were supine and had baseline value taken was the average of three predrug been fasting for at least eight hours. Each study day determinations, and the peak response was the average began with a 60-minute baseline infusion of PAH and of the two highest consecutive values. inulin prior to drug administration to determine baseline Pearson's correlation was used to test the association renal plasma flow (RPF) and glomerular filtration rate of the renal response to candesartan with the response (GFR), respectively. Hormonal measurements were to captopril. Paired t-test was used to compare the renal made on blood samples obtained at baseline and at four vascular and PRA responses to captopril and candesarand eight hours after drug administration while the subtan. The subjects were then divided into two groups: jects were lying supine.
those in whom the RPF response to captopril was normal The study was designed to compare the renal hemodyand those in whom the response was accentuated to denamic response to captopril and to candesartan. On the termine whether there were differences in renin activity. first morning, the patients received captopril (25 mg
Fisher's exact test, t-test, and Mann-Whitney rank sum orally). On the next morning, the patients received cantest were used to compare the characteristics and the renal desartan (16 mg orally). These doses were chosen behemodynamic and PRA responses of these two groups. cause both represent the top of the relationship between Analysis of covariance (ANCOVA) was performed to dose and RPF response.
account for possible confounding effects of baseline charBlood pressure was recorded during each infusion acteristics on RPF response to the two drugs. by an automatic recording device (Dinamap; Critikon, Tampa, FL, USA) at five-minute intervals.
RESULTS
Renal clearance studies
Baseline characteristics of the subjects are listed in Table 1 . The high-salt balance, as evidenced by a 24-hour Para-aminohippurate (PAH; Merck, Sharp & Dohme, urine sodium excretion of 254 Ϯ 34.9 mEq, resulted in Rahway, NJ, USA) and inulin (Inutest; Fresenius Pharma suppression of the renin-angiotensin system (RAS) at Austria GmbH, Linz, Austria) clearances were assessed baseline, as anticipated. after metabolic balance was achieved. A control blood
The average blood glucose achieved during the captosample was drawn, and then loading doses of PAH pril study was not significantly different from that during (8 mg/kg) and inulin (50 mg/kg) were given intravenously. A constant infusion of PAH and inulin was initithe candesartan study (119 Ϯ 35 vs. 127 Ϯ38 mg/dL, P ϭ significantly different from the response to candesartan (P ϭ 0.13); however, the time to peak was different for the two drugs. Captopril had achieved the greatest to the two drugs (P ϭ 0.239). When baseline RPF, baseresponse by 90 to 135 minutes, while the response to line GFR, and baseline PRA were added as covariates, candesartan was still rising at 225 minutes. Baseline and the responses remained not significantly different from peak GFRs were likewise not significantly different beeach other (P ϭ 0.345). tween the two drugs. There was no significant change in Plasma renin activity levels were equally suppressed GFR either in response to captopril or to candesartan at baseline on both days (Table 3 ). The PRA response to (P ϭ 0.74 and P ϭ 0.45, respectively).
captopril did not differ from the response to candesartan The RPF responses to captopril and to candesartan (Table 3) , although a trend toward a larger response to showed remarkable concordance (r ϭ 0.86, P Ͻ 0.001; candesartan was evident. Fig. 2 ). With an r 2 of 0.74, 74% of the variation in the The RPF response to captopril in normal humans response to captopril was accounted for on the basis of when the renin system is suppressed by a high-salt diet the response to candesartan. Using ANCOVA, there was no significant difference between the RPF response is less than 30 mL/min/1.73 m 2 [26, 27] . On that basis, In the five patients in whom the response to captopril was minimal, the response to candesartan was also minimal. In the seven patients in whom the response to captopril was accentuated, the response to sartan and to captopril in the patients with type 1 diabetes mellitus subdivided according to whether the renal response to captopril was candesartan was accentuated equally or more (Fig. 2) .
in the normal range or accentuated. Note that baseline RPF was signifi-
The seven patients with the accentuated response did cantly higher in the patients in whom the renal hemodynamic response not differ from the five with normal RPF responses in to captopril, and to candesartan, was accentuated. Symbols are: (᭹) accentuated response; (᭺) normal response.
terms of gender (P ϭ 1.000), age (30 Ϯ 4.7 vs. 36 Ϯ 8.9 years, P ϭ 0.52), fasting blood sugar (123 Ϯ 17 vs. 123 Ϯ 7 mg/dL, P ϭ 0.99), or HbA1C (7.3 Ϯ 0.5 vs. 6.4 Ϯ 0.5%, P ϭ 0.22) nor in terms of the average blood reaches its peak in the first four hours and is sustained glucose level achieved following captopril (120 Ϯ 8 vs.
for the next four hours [31] . The correlation coefficient 117 Ϯ 8 mg/dL, P ϭ 0.82) or candesartan (128 Ϯ 10 between the RPF responses to captopril and to candesarvs. 127 Ϯ 10 mg/dL, P ϭ 0.94). Moreover, the two groups tan was 0.86 (P Ͻ 0.001). As candesartan specifically did not differ either in baseline PRA or in PRA response blocks the AT 1 receptor to prevent the action of Ang II, (Table 4) . However, there was a significant difference this implies that the dominant effect of ACE inhibition in baseline RPF between the groups. On both study days, was likewise on the Ang II pathway. Thus, it is unlikely the patients who showed an accentuated RPF response that other pathways, such as those involving bradykinin, had higher baseline RPF than those who showed a norprostaglandin, and nitric oxide, contribute substantially mal response (captopril 623 Ϯ 26 vs. 505 Ϯ 44 mL/min/ to the renal response to ACE inhibition in accord with 1.73 m 2 , P ϭ 0.04; candesartan 625 Ϯ 28 vs. 509 Ϯ 32, other observations in humans [32] . The same conclusion P ϭ 0.02; Fig. 3) .
was reached in a study by Gansevoort, De Zeeuw, and De Jong in normal subjects, in whom the Ang II antago-DISCUSSION nist losartan had effects on renal hemodynamics similar to the ACE inhibitor enalapril [33] . However, unlike Our goal was to ascertain whether or not the mechatheir study, ours includes a patient-by-patient analysis nism for the enhanced renal hemodynamic response to rather than a comparison of group means. ACE inhibition in patients with type 1 diabetes mellitus Although indirect, this approach to testing our hypothwas predominantly caused by reduced Ang II formation esis is one of the few methods available in humans. In [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Few studies have attempted to delineate this two earlier studies, the same principle of a shared action mechanism in humans, and these have largely focused of two pharmacologically distinct drugs-an ACE inhibion normal subjects on a low-salt diet in order to activate tor and an Ang II antagonist-was also involved in exthe RAS [28] [29] [30] . This study in diabetic patients on a plaining the renal hemodynamic effects of ACE inhibihigh-salt diet has therapeutic implications, given that tion [28, 29] . The only other mechanistic study in humans this population has been shown to benefit from ACE involved administration of captopril alone, captopril plus inhibition and that their typical diet more likely includes the bradykinin receptor antagonist, icatibant (HOE 140), liberal salt intake rather than rigid sodium restriction.
or losartan alone. Renal vascular resistance decreased Both captopril and candesartan induced significant into a similar extent in all three phases, indicating that creases in RPF. Because RPF determinations were not bradykinin did not play a significant role in the renal made beyond 225 minutes, it might seem that the peak response to ACE inhibition [30] . response to candesartan was not captured. However, we have previously shown that the RPF response already One possible limitation of this study involves the fact that the sequence of captopril and candesartan adminissibility of intrarenal activation of the RAS that is not reflected in plasma levels. A similar pattern occurs in tration was not random. Our goal was to study the response to the two agents in as short an interval as possinormal humans when hyperglycemia enhances the renal hemodynamic response to pharmacological interruption ble, and candesartan has a duration of action of at least 48 hours [31] . Captopril, on the other hand, shows a of the renin system, yet PRA remains unchanged [26, 27] . Another feature of the renal hemodynamic response response that fades rapidly after two to three hours [34] . For that reason, captopril was administered first in each to hyperglycemia was also evident in our patients. Hyperglycemia induced acutely over a period of one hour insubject. Our thesis was that if the response to captopril had a duration longer than we anticipated, it would have creases RPF and also increases the response to pharmacological interruption with ACE inhibitors and Ang II been expressed in baseline PRA level and RPF prior to candesartan administration. As both measures were esantagonists [26, 27] . This paradoxical relationship, a larger renal vasodilator response to pharmacological insentially identical at baseline on the two days, it is unlikely that a sustained action of captopril influenced the terruption of the renin system being associated with higher RPF at baseline, was evident not only in our paresults. However, despite this observation, the possibility of a carryover effect cannot be ruled out with certainty.
tients with type 1 diabetes in this study, but also in patients with type 2 diabetes and nephropathy as we have reThere is evidence of RAS activation in diabetic subjects who are hyperglycemic. In Miller et al's study on ported recently [37] . Thus, it is possible that the forces responsible for vasodilation and the forces responsible type 1 diabetic patients, hyperglycemia produced higher PRA levels compared with euglycemia, both at baseline for activation of the intrarenal RAS are in some way related. Studies by our group are currently being underwhen patients were lying supine and during periods of orthostatic stress induced by lower body negative prestaken to investigate the factors determining the level of baseline RBF (abstract; Laffel et al, J Am Soc Nephrol sure [35] . To assess further the implications for the kidney of the RAS activation in patients with type 1 diabetes, 9:117a, 1998). The possibility of genetic determinants, for example ACE gene polymorphisms, is especially atthe same investigator reported decreased baseline effective RPF (ERPF) and renal blood flow (RBF) after intractive, although the present study was not powered to address this issue. In animal studies, the renal hemodyducing hyperglycemia over a period of approximately 12 hours and a significant increase in ERPF upon adminnamic response to hyperglycemia has been attributed, at least in part, to activation of nitric oxide synthase [38] . istration of the Ang II antagonist losartan while maintaining a hyperglycemic state. There was no significant Moreover, there has been substantial recent interest in a continuing interaction between nitric oxide and RAS change in either ERPF or RBF during euglycemia [36] . These experiments support the hypothesis that hyperglyas part of normal renal homeostasis [39] . How does hyperglycemia activate the RAS? One cemia affects renal hemodynamics by activating the RAS.
Activation of the RAS in these subjects with type 1 might invoke a reduced extracellular fluid volume from osmotic diuresis as the mechanism. Other studies, howdiabetes suggested strongly by the highly concordant renal hemodynamic response to captopril and to candeever, show no evidence of intravascular volume depletion during hyperglycemia [32, 40] . In a study by Woods, sartan was not evident in measures of PRA. By this index the renin system was suppressed, as anticipated, from Mizelle, and Hall, a tubuloglomerular feedback mechanism was implicated since intrarenal infusion of glucose the high-salt intake. These observations suggest the pos- 
